Bespoke human hypertrophic chondrocytic cell lines provide the osteoinductive signals required for vascularized bone formation

Tissue Engineering

Volumn 13, Issue 1, 2007, Pages 133-145

  Stringer, Bradley ^a   Waddington, Rachel ^a   Sloan, Alastair ^a   Phillips, Ian ^b   Telford, Gary ^c   Hughes, David ^d   Craig, Geoffrey ^b   Gangemi, Lavinia ^b   Brook, Ian ^b   Freeman, Christine ^b   Cao, Xuesong ^b   Gosal, Mandeep ^b   Smith, Simon ^b   Russell, Graham ^e   Foster, George ^f  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOMEDICAL ENGINEERING; BONE; CARTILAGE; FRACTURE;

CLINICAL USE; HUMAN BONE MARROW; HYPERTROPHIC CHONDROCYTIC CELL; OSTEOINDUCTIVE SIGNALS;

CELLS;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; BONE GRAFT; BONE GROWTH; BONE MARROW CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CELL DIVISION; CELL IMMORTALIZATION; CONFERENCE PAPER; CONTROLLED STUDY; FEMUR; FRACTURE HEALING; HUMAN; HUMAN CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE ENGINEERING;

ANIMALS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CHONDROCYTES; CLONE CELLS; HUMANS; HYPERTROPHY; MALE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

RATTUS;

EID: 33846570852     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.0111     Document Type: Conference Paper

References (61)

1. Wang, E.A., Rosen V., D'Alessandro, J.S., Bauduy, M., Cordes, P., Harada, T., Israel, D.I., Hewick, R.M., Kerns, K.M., LaPan, P., Luxenberg, D.H., McQuid, D., Moutsatsos, I.K., Nove, J., and Wozney J.M. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. USA 87, 2220, 1990.
2. Yasko, A.W., Lane, J.M., Fellinger, E.J., Rosen, V., Wozney, J.M., and Wang, E.A. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J. Bone Joint Surg. (Am.) 74, 559, 1992.
3. Linde, A., and Hedner E. Recombinant bone morphogenetic protein-2 enhances bone healing, guided by osteopromotive e-PTFE membranes: an experimental study in dogs. Calcif. Tissue Int. 56, 549, 1995.
4. Sampath, T.K., Maliakal J.C., Hauschka, P.V., Jones, W.K., Sasak, H., Tucker R.F., White, K.H., Coughlin J.E., Tucker M.M., and Pang, R.H. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267, 20352, 1992.
5. Boyne, P.J., Marks, R.E., Nevins, M., Triplett, G., Lazaro, E., Lilly, L.C., and Nummikoski, P. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int. J. Periodont. Rest. Dent. 17, 10, 1997.
6. Howell, T.H., Florellini, J., Jones, A., Alder, M., Nummikoski, P., Lazaro, M., Lilly, L., and Cochran, D. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int. J. Periodont. Rest. Dent. 17, 125, 1997.
7. Geesink, R.G.T., Hoefnagels, N.H.M., and Bulstra, S.K Osteogenic activity of OP-1, bone morphogenetic protein-7 (BMP-7), in a human fibular defect model. J. Bone Joint Surg. (Br.) 81, 710, 1999.
8. Groeneveld, H.H.J., Van den Bergh, J.P.A., Ten Bruggenkate, C.M., Tuinzing, D.B., and Burger, E.H. Histomorphometrical analysis of bone formed in human maxillary sinus floor elevations grafted with OP-1 device, demineralised bone matrix or autogenous bone. Comparison with non-grafted sites in a series of case reports. Clin. Oral Implants Res. 10, 499, 1999.
9. Lane, J.M. BMPs: Why are they not in every day use? J. Bone Joint Surg. (Am.) 83A, S161, 2001.
10. Friedlander, G.E. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial non-unions. J. Bone Joint Surg. (Am.) 83A Suppl (Pt 2), S151, 2001.
11. Khan, S.N., and Lane, J.M. The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications. Expert Opin. Biol. Ther. 4, 741, 2004.
12. Solchaga, L. A., Cassiede, P., and Caplan, A.I. Different response to osteoinductive agents in bone marrow- and periosteum-derived cell preparations. Acta Orthop. Scand. 69, 426, 1998.
13. Yaszemski, M.J., Payne, R.G., Hayes, W.C., Langer, R., and Mikos, A.G. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 17, 175, 1996.
14. Summers, B.N., and Einstein, S.M. Donor site pain from the ileum: a complication of lumbar spine fusion. J. Bone Joint Surg. (Br.) 71B, 677, 1989.
15. Sawin, P.D., Traynelis, V.C., and Menezes, A.H. A comparative analysis of fusion rates and donor-site morbidity for autogeneic rib and iliac crest bone grafts in posterior cervical fusions. J. Neurosurg. 88, 255, 1998.
16. Norman-Taylor, F.H. The trouble with bone allograft. Br. Med. J. 315, 498, 1997.
17. Simonds, R.J., Holmberg, S.D., Hurwitz, R.L., Coleman, T.R., Bottenfield, S., Conley, L.J., Kohlenberg, S.H., Castro, K.G., Dahan, B.A., and Schable, C. A. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N. Engl. J. Med. 326, 726, 1992.
18. Boyce, T., Edwards, J., and Scarborough, N. Allograft bone. The influence of processing on safety and performance. Orthop. Clin. North Am. 30, 517, 1999.
19. Schultz, O., Sittinger, M., Haeupl, T., and Burmster, G.R. Emerging strategies of bone and joint repair. Arthritis Res. 2, 433, 2000.
20. Ashton, B.A., Allen, T.D., Howlett, C.R., Eaglesom, C.C., Hattori, A., and Owen, M. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin. Orthop. Relat. Res. 151, 294, 1980.
21. Ohgushi, H., Goldenberg, V.M., and Caplan, A.I. Heterotopic osteogenesis in porous ceramics induced by marrow cells. J. Orthop. Res. 7, 568, 1989.
22. Quarto, R., Mastrogiacomo, M., Cancedda, R., Kutepov, S.M., Mukhachev, V., Lavroukov, A., Kon, E., and Marcacci, M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Med. 344, 385, 2001.
23. Bellows, G.G., Heersche, J.N.M., and Aubin, J.E. Determination of the capacity for proliferation and differentiation of osteoprogenitor cells in the presence and absence of dexamethasone. Dev. Biol. 140, 132, 1990.
24. Banfi, A. Muraglia, A., Dozin, B., Mastrogiacomo, M., Cancedda, R., and Quarto, R. Proliferation kinetics and differentiation of ex vivo expanded human bone marrow stromal cells: implication for their use in cell therapy. Exp. Haematol. 28, 707, 2000.
25. Muschler, G.F., Nakamoto, C., and Griffith, L.G. Engineering principles of clinical cell-based tissue engineering. J. Bone Joint Surg. (Am.) 86, 1541, 2004.
26. Kirk, M.D., and Kahn, A.J. Extracellular matrix synthesised by clonal osteogenic cells is osteoinductive in vivo and in vitro: role of transforming growth factor-beta1 in osteoblast cell-matrix interaction. J. Bone Miner. Res. 10, 1203, 1995.
27. Hunt, T.R., Schwappach, J.R., and Clarke, A.H. Healing of a segmental defect in the rat femur with use of an extract from a cultured human osteosarcoma cell-line (Saos-2). A preliminary report. J. Bone Joint Surg. (Am.) 78A, 41, 1996.
28. Langman, J. Langman's Medical Embryology, 9th ed. Philadelphia: Lippincott, Williams and Wilkins, 2004.
29. Houghton, A., Oyajobi, B.O., Foster, G.A., Russell, R.G.G., and Stringer, B.M.J. Immortalisation of human marrow stromal cells by retroviral transduction with a temperature sensitive oncogene: identification of bipotential precursor cells capable of directed differentiation to either osteoblast or adipocyte phenotype. Bone 22, 7, 1998.
30. Oyajobi, B.O. Houghton, A., Hatton, P., Frazer, A., Graveley, R., Russell, R.G.G., and Stringer, B.M.J. Expression of type X collagen and matrix calcification in three-dimensional cultures of immortalised temperature- sensitive chondrocytes derived from adult human. J. Bone Miner. Res. 13, 432, 1998.
31. Crosthwaite, N., Teale, D., Franklin, C.D., Foster, G.A., and Stringer, B.M.J. p53 protein expression in malignant, premalignant and non-malignant lesions of the lip. J. Clin Pathol. 49, 1, 1996.
32. Yanai, N., and Obinata, M. Apoptosis is induced at nonpermissive temperature by a transient increase in p53 in cell lines immortalised with temperature sensitive SV40 large-T antigen gene. Exp. Cell Res. 211, 296, 1994.
33. Cancedda R., Descalzi-Cancedda F., and Castagnola P. Chondrocyte differentiation. Int. Rev. Cytol. 159, 265, 1995.
34. Fukunaga, T., Yamashiro, T., Oya, S., Takeshita, N., Takigawa, M., and Takano-Yamamoto, T. Connective tissue growth factor mRNA expression pattern in cartilages is associated with their type I collagen expression. Bone 33, 911, 2003.
35. Nakanishi, T., Kimura, Y., Tamura, T., Ichikawa, H., Yamaai, Y., Sugimoto, T., and Takigawa, M. Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA. Biochem. Biophys. Res. Commun. 234, 206, 1997.
36. Tuckermann, J.P., Pittois, K., Partridge, N.C., Merregaert, J., and Angel, P. Collagenase-3 (MMP-13) and integral membrane protein 2a (Itm2a) are marker genes of chondrogenic/osteoblastic cells in bone formation: sequential temporal, and spatial expression of Itm2a, alkaline phosphatase, MMP-13, and osteocalcin in the mouse. J. Bone Miner. Res. 15, 1257, 2000.
37. Rahman, M.M., Iida, H., and Shibata, Y. Expression and localization of annexin V and annexin VI during limb bud formation in the rat fetus. Anat. Embryol. (Berl). 195, 31, 1997.
38. Friedenstein, A.J., Gorskaja, J.F., and Kulagina, N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 4, 267, 1976.
39. Zhang, R.W., Supowit, S.C., Xu, X., Li, H., Christensen, M.D., Lozano, R., and Simmons D.J. Expression of selected osteogenic markers in the fibroblast-like cells of rat marrow stroma. Calcif. Tissue Int. 56, 283, 1995.
40. Scutt, A., and Bertram, P. Bone marrow cells are targets for the anabolic actions of PGE2: induction of a transition from non-adherent to adherent osteoblast precursors. J. Bone Miner. Res. 10, 474, 1995.
41. Scutt, A., and Bertrum, P. Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow stromal cells. Calcif. Tissue. Int. 64, 69, 1999.
42. Shimizu-Ishiura, M., Tanaka, S., Lee, W.S., Debari, K., and Sasaki, T. Effects of enamel matrix derivative to titanium implantation in rat femurs. J. Biomed. Mater. Res. 60, 269, 2002.
43. Reikeras, O., Johansson, C.B., and Sundfeldt, M. Hydroxyapatite and carbon coatings for fixation of unloaded titanium implants. J. Long Term Eff. Med. Impl. 14, 443, 2004.
44. Lynn, A.K., Yannas, I.V., and Bonfield, W. Antigenicity and immunogenicity of collagen. J. Biomed. Mater. Res. Part B: Appl. Biomater. 71B, 343, 2004.
45. Nikolopoulos, S., Peteinaki, E., and Castanas, E. Immunologic effects of Emdogain in humans: one-year results. Int. J. Periodont. Restor. Dent. 22, 269, 2002.
46. Groeneveld, E.H.J., and Burger, E.H. Bone morphogenetic proteins in human bone regeneration. Eur. J. Endocrinol. 142, 9, 2000.
47. Hollinger, J.O., Winn, S., and Bonadio, J. Options for tissue engineering to address challenges of the aging skeleton. Tissue Eng. 6, 341, 2000.
48. Braddock, M., Houston, P., Campbell, C., and Ashcroft, P. Born again bone: tissue engineering for bone repair. News Physiol. Sci. 16, 208, 2001.
49. Jadlowiec, J.A., Celil, A.B., and Hollinger, J.O. Bone tissue engineering: recent advances and promising therapeutic agents. Expert Opin. Biol. Ther. 3, 409, 2003.
50. Valentin-Opran, A., Wozney, J., Csimma, C., Lilly, L., and Riedel, G.E. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin. Orthop. 395, 110, 2002.
51. Poynton, A.R., and Lane, J.M. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 27, S40, 2002.
52. King, G.N., and Cochran, D.L. Factors that modulate the effects of bone morphogenetic protein-induced periodontal regeneration: a critical review. J. Periodontol. 73, 925, 2002.
53. Geiger, M., Li, R.H., and Friess, W. Collagen sponges for bone regeneration with rhBMP-2. Adv. Drug Deliv. Rev. 55, 1613, 2003.
54. Lutolf, M.P., and Hubbell, J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotech. 23, 47, 2005.
55. Bianco, P., and Robey, P.G. Marrow stromal stem cells. J. Clin. Invest. 105, 1663, 2000.
56. Bruder, S.P., Kraus, K.H., Goldberg, V.M., and Kadiyala, S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J. Bone Joint Surg. (Am.) 80, 985, 1998.
57. Mankani, M.H., Krebsbach, P.M., Satomura, K., Kuznetsov, S.A., Hoyt, R., and Robey, P.G. Pedicled bone flap formation using transplanted bone marrow stromal cells. Arch. Surg. 136, 263, 2001.
58. Horwitz, E.M. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 5, 309, 1999.
59. Petite, H., Viateau, V., Bensaid, W., Meunier, A., Pollak, Cd., Bourguignon, M., Oudina, K., Sedel, S., and Guillemin, G. Tissue-engineered bone regeneration. Nat. Biotech. 18, 959, 2000.
60. Krebsbach, P.H., Mankani, M.H., Satomura, K., Kuznetsov, S.A., and Robey, P.G. Repair of craniotomy defects using bone marrow stromal cells. Transplantation 6, 1272, 1998.
61. Kon, E., Muraglia, A., Corsi, A., Bianco, P., Marcacci, M., Martin, I., Boyde, A., Ruspantini, I., Chistolini, P., Rocca, M., Giardino, R., Cancedda, R., and Quarto R. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J. Biomed. Mater. Res. 49, 328, 2000.